Page last updated: 2024-10-21

menthol and Osteoporosis

menthol has been researched along with Osteoporosis in 1 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"In the clinical setting, raloxifene, a second-generation selective estrogen receptor modulator, is administered orally; however, the bioavailability (BA) is only 2% because of its poor solubility in aqueous fluids and its extensive first-pass metabolism."1.48Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. ( Kawasaki, N; Nagai, N; Nakazawa, Y; Ogata, F; Otake, H, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagai, N1
Ogata, F1
Otake, H1
Nakazawa, Y1
Kawasaki, N1

Other Studies

1 other study available for menthol and Osteoporosis

ArticleYear
Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Cutaneous; Animals; Biological Availability; Body Weight; Calcium; Chemistry, Pharma

2018